BIRKBY HEALTH CENTRE — All Prescriptions & Medications — Page 8

Practice Code: B85634 | HUDDERSFIELD, HD2 2YD

Showing results 351-400 of 411

MedicationItems (12m) ↓QuantityCostvs National
Zuclopenthixol hydrochloride151,500£161-52.4% ▼
Pyridoxine hydrochloride1513.1K£2.2K-30.2% ▼
Nabumetone15840£246+7.9% ▲
Ketoconazole15480£65+50.8% ▲
15390£534+39.9% ▲
152,900£43-11.2% ▼
1529£173-58.0% ▼
1529£162-55.6% ▼
15310£168-28.0% ▼
Aciclovir14893£34-90.6% ▼
Metformin hydrochloride/pioglitazone141,456£888+10.8% ▲
Leuprorelin acetate1414£3.2K-69.8% ▼
Azelaic acid14510£98-41.4% ▼
Salicylic acid14153£49+10.7% ▲
14420£523-10.8% ▼
Edoxaban13504£838-98.1% ▼
Umeclidinium bromide1322£575-78.9% ▼
Guaifenesin131,875£55+351.4% ▲
Loprazolam mesilate13364£287-1.8% vs avg
Temazepam1391£82-77.3% ▼
Chlorpromazine hydrochloride13728£442-66.9% ▼
Topiramate131,614£65-92.7% ▼
Vardenafil13392£713-6.9% ▼
Sevelamer133,258£1.1K-40.7% ▼
Heparinoid132,740£153-50.4% ▼
Timolol13270£68-85.3% ▼
13130£16-65.4% ▼
Diltiazem hydrochloride12360£151+159.1% ▲
Erythromycin121,356£605-65.4% ▼
Terbinafine hydrochloride12588£246-80.6% ▼
Metformin hydrochloride/sitagliptin121,344£243-67.9% ▼
Tube feed 1.5 kcal/ml with fibre (0914011)12170.5K£3.3K+3.8% ▲
Pyridostigmine bromide124,800£386-29.9% ▼
Azelastine hydrochloride12128£97+1.0% vs avg
Phenazone/lidocaine12180£102+17.3% ▲
Calamine122,300£18+58.3% ▲
121,200£67-85.9% ▼
12850£64-82.8% ▼
1285£251-50.4% ▼
Sodium citrate (Rectal)11492£317-20.3% ▼
Torasemide11308£103-2.0% ▼
Fenofibrate11308£34-88.6% ▼
Metoclopramide hydrochloride11573£36-86.7% ▼
Ibuprofen sodium dihydrate11704£103+60.0% ▲
Methylprednisolone acetate1112£57-90.5% ▼
Capsaicin11945£291+39.3% ▲
Emulsifying wax119,500£70-9.7% ▼
11550£50-7.7% ▼
1111£53-73.0% ▼
Valsartan/amlodipine10560£431-8.8% ▼
← Back to BIRKBY HEALTH CENTRE
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.